William Blair analyst Ben Andrew maintained an Outperform rating on Abiomed (NASDAQ:ABMD), following the release of the company’s fiscal third-quarter results that topped Street …
In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Abbott Laboratories (NYSE:ABT). No price target was …
In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on St. Jude Medical (NYSE:STJ).
In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Dexcom (NASDAQ:DXCM). No price target was provided.
In a research note issued today, William Blair analyst Ben Andrew reiterated an Outperform rating on Insulet (NASDAQ:PODD), following the news that the Chief …
In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Intuitive Surgical (NASDAQ:ISRG). No price target was …
In a research note released yesterday, William Blair analyst Ben Andrew maintained an Outperform rating on Intuitive Surgical (ISRG) ahead of the upcoming …
In a research note issued yesterday, William Blair analyst Ben Andrew reaffirmed an Outperform rating on Abbott Laboratories (ABT). The report followsyesterday’s news that Abbott will …
Analyst Ben Andrew of William Blair upgraded Medtronic, Inc. (MDT) from Market Perform to Outperform in a research report released on today.
